Archives

by in
Entry Author Date Location
Texas Roundup: Bellicum, Spredfast, People Pattern, Neos, Localeur 01/07/14 Texas
Report: Dendreon Looking to Get Acquired 10/26/13 Seattle
Buoyed by Partnerships, Bind Therapeutics Floats $80.5M IPO Plan 08/12/13 Boston
Dendreon Says Sales Will Decline in 2013, Shares Fall 08/08/13 Seattle
Texas Roundup: Appconomy, Bellicum, and Datafiniti 07/12/13 Texas
San Diego Life Sciences Roundup: Aragon, Santarus, Tocagen, and More 06/20/13 San Diego
Isis Execs Upbeat as AstraZeneca Expands Cancer Drug Collaboration 06/05/13 San Diego
Genomic Health Test Aims To Cut Overtreatment of Prostate Cancer 05/08/13 San Francisco
Why Are Healthcare Costs Exploding? See Proton Cancer Therapy 03/18/13 National
Prostate Cancer Drug Winners and Losers at ASCO GU 02/15/13 National
Tokai Looks to Follow Fast Behind J&J, Medivation in Prostate Cancer 02/13/13 Boston
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
Dendreon Shareholders Vent at Annual Meeting 06/13/12 Seattle
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say 05/16/12 Seattle
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up 03/08/12 Seattle
San Diego’s Aragon Raises $42 Million, Targets Hormone-Driven Cancers 03/06/12 San Diego
Dendreon Adds ImClone Vets to New Management Team 02/28/12 Seattle
SD Life Sciences Roundup: Celladon, Gen-Probe, Organovo, and More 02/16/12 National
FDA Approves New Gen-Probe Test for Men at Risk of Prostate Cancer 02/15/12 San Diego
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership 01/17/12 San Francisco
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms 01/05/12 Seattle
Dendreon Edges Past Street Expectations With Third Quarter Provenge Sales, Shares Still Fall 11/02/11 Seattle
Page 2 of 8 « previous page · next page »